From Lab to Clinic: Utilizing Advanced Small Molecule Drug Discovery Market Research to Optimize Hit-to-Lead Processes
Fragment-based drug design (FBDD) is gaining significant traction as a more efficient alternative to traditional high-throughput screening. By identifying small, low-molecular-weight "fragments" that bind weakly to a target, chemists can grow or link these fragments into highly potent leads. This approach often results in molecules with better ligand efficiency and more favorable...
0 Comments 0 Shares 716 Views 0 Reviews